I have no doubt that Leo is working his @$$ off for us shareholders. This is his email to Cabel from two weeks ago, in case someone missed it. My favorite part is bolded.
Quote:Hi Pat,
There are so many emails that deserve custom responses, but it's not possible now as it would take up half my day instead of working on other urgent company matters. I have prepared the following response for now.
Thank you very much for the email and your comments. We certainly feel that we have many exciting drug developments ongoing and a great future ahead of us. With the support of our loyal shareholders, we’ve worked relentlessly over the years to successfully advance our pipeline and believe that we now stand at the precipice of a major transformation. There are challenges, of course, which we recognize. As you are probably aware, we have a passionate and active shareholder base. I have received many, many emails like yours since the release of the top-line data from the Prurisol trial, Kevetrin data being finalized and victory over the Rosen Law Firm. Many positive developments only just happened and we are currently in the process of analyzing data, fielding questions from others in the industry, conducting meetings, etc. to decide the best route forward. As I am always transparent, my intent is to provide a comprehensive update on the company in the near future to answer everyone’s questions that will explain, in a nutshell, what’s next
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
